Home
>
National Drug Code (NDC)
>
JANUVIA
JANUVIA - 0006-0221-31 - (sitagliptin)
Drug Information of JANUVIA
| Product NDC: | 0006-0221 |
| Proprietary Name: | JANUVIA |
| Non Proprietary Name: | sitagliptin |
| Active Ingredient(s): | 25 mg/1 & nbsp; sitagliptin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of JANUVIA
| Product NDC: | 0006-0221 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021995 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20061016 |
Package Information of JANUVIA
| Package NDC: | 0006-0221-31 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31) |
NDC Information of JANUVIA
| NDC Code | 0006-0221-31 |
| Proprietary Name | JANUVIA |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31) |
| Product NDC | 0006-0221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sitagliptin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20061016 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | SITAGLIPTIN PHOSPHATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
